Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
- 1 April 2010
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (4), 597-603
- https://doi.org/10.3324/haematol.2009.012864
Abstract
Translocations involving the MYC gene and increased MYC mRNA levels are associated with poor outcome in diffuse large B-cell lymphoma. However, the presence of increased MYC gene copy number and/or polysomy of chromosome 8 have not been previously described. Utilizing dual color chromogenic in situ hybridization, we investigated MYC gene copy and chromosome 8 centromere numbers in 52 cases of diffuse large B-cell lymphoma. Cases were divided into those with "increased" or "not increased" MYC gene copy number for comparison with MYC mRNA levels, Ki-67 values, and survival. Increased MYC gene copy number was present in 38% of cases. Overall, the average MYC mRNA level was 2398 (range, 342 - 9783) and the percentage of nuclei positive for Ki-67 was 57.5% (range, 20-87%). Within the group with increased MYC copy number, the MYC mRNA values ranged from 816 to 5912 (average, 2843) and the Ki-67 values ranged from 23% to 83% (average, 57%). Within the group with not increased MYC copy number, MYC mRNA values ranged from 342 to 9783 (average, 2118) and the Ki-67 values ranged from 20% to 87% (average, 58%). There was a statistically significant relationship between increased MYC gene copy number and increased MYC mRNA (P=0.034) and a trend toward a relationship between increased mRNA and higher Ki-67 values. This is the first report that low level copy number increases are common in diffuse large B-cell lymphoma and that these changes correlate with MYC mRNA in a statistically significant manner. MYC copy number changes are an additional possible molecular mechanism that may result in increased mRNA and, likely, high proliferation and poor outcome.Keywords
This publication has 38 references indexed in Scilit:
- Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphomaBlood, 2009
- Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOPBlood, 2008
- Development of automated brightfield double In Situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence In Situ hybridization (FISH)Diagnostic Pathology, 2008
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibitionThe EMBO Journal, 2007
- Supercoil-driven DNA structures regulate genetic transactionsFrontiers in Bioscience-Landmark, 2007
- c-Myc-regulated microRNAs modulate E2F1 expressionNature, 2005
- Quadruplex–duplex competition in the nuclease hypersensitive element of human c-myc promoter: C to T mutation in C-rich strand enhances duplex associationBiochemical and Biophysical Research Communications, 2005
- Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six GenesThe New England Journal of Medicine, 2004
- A Nuclease Hypersensitive Element in the Human c-myc Promoter Adopts Several Distinct i-Tetraplex StructuresBiochemical and Biophysical Research Communications, 2000